Related Experiment Video
Updated: Jul 13, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Patched acts catalytically to suppress the activity of Smoothened
J Taipale1, M K Cooper, T Maiti
1Howard Hughes Medical Institute, Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Abstract:
Mutations affecting the transmembrane proteins Patched (Ptc) or Smoothened (Smo) that trigger ligand-independent activity of the Hedgehog (Hh) signalling pathway are associated with human tumours such as basal cell carcinoma (BCC) and medulloblastoma. Despite extensive genetic studies demonstrating the importance of these receptor components in embryonic patterning and cancer, the mechanism by which Ptc regulates Smo is not understood. Here we report that Ptc and Smo are not significantly associated within Hh-responsive cells. Furthermore, we show that free Ptc (unbound by Hh) acts sub-stoichiometrically to suppress Smo activity and thus is critical in specifying the level of pathway activity. Patched is a twelve-transmembrane protein with homology to bacterial proton-driven transmembrane molecular transporters; we demonstrate that the function of Ptc is impaired by alterations of residues that are conserved in and required for function of these bacterial transporters. These results suggest that the Ptc tumour suppressor functions normally as a transmembrane molecular transporter, which acts indirectly to inhibit Smo activity, possibly through changes in distribution or concentration of a small molecule.
Insights
Patched (Ptc) protein suppresses Hedgehog (Hh) pathway activity by indirectly inhibiting Smoothened (Smo). Ptc functions as a molecular transporter, crucial for regulating pathway levels in development and cancer.
Area of Science:
- Molecular Biology
- Developmental Biology
- Cancer Research
Background:
- Mutations in Patched (Ptc) and Smoothened (Smo) activate the Hedgehog (Hh) signaling pathway.
- Hh pathway dysregulation is linked to human cancers like basal cell carcinoma (BCC) and medulloblastoma.
- The precise mechanism of Ptc regulation of Smo remains unclear despite genetic evidence.
Purpose of the Study:
- To elucidate the mechanism by which Patched (Ptc) regulates Smoothened (Smo) activity.
- To investigate the functional relationship between Ptc and Smo in Hh signaling.
- To determine the role of Ptc's transmembrane transporter-like structure in its function.
Main Methods:
- Assessed the physical association between Ptc and Smo in Hh-responsive cells.
- Quantified the effect of unbound Ptc on Smo activity.
- Mutagenesis of conserved residues in Ptc, homologous to bacterial transporters, to assess functional impact.
Main Results:
- Patched (Ptc) and Smoothened (Smo) do not significantly associate within Hh-responsive cells.
- Free Ptc (unbound by Hh) suppresses Smo activity in a sub-stoichiometric manner, controlling pathway levels.
- Altering conserved residues in Ptc, analogous to bacterial transporter functions, impairs Ptc's tumor-suppressive activity.
Conclusions:
- Patched (Ptc) functions indirectly to inhibit Smoothened (Smo) activity, likely via a transmembrane molecular transporter mechanism.
- Ptc's role as a transporter is critical for regulating Hh pathway activity levels.
- This mechanism is potentially mediated by modulating the distribution or concentration of a small molecule.
Related Concept Videos
Feedback Inhibition
Drugs that Stabilize Microtubules
Hedgehog Signaling Pathway
Inhibition of Cdk Activity
TGF - β Signaling Pathway
Inhibition of CDK Activity

